Octagon Therapeutics, Inc.
Pharmaceutical company · Providence, Rhode Island, United States
Octagon Therapeutics, Inc. is a pharmaceutical company headquartered in Providence, Rhode Island, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2024.
Octagon Therapeutics at a glance
What does Octagon Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $11 million sold (2024).
Frequently asked questions about Octagon Therapeutics
Where is Octagon Therapeutics headquartered?
Octagon Therapeutics, Inc. is headquartered in Providence, Rhode Island, United States.
What does Octagon Therapeutics do?
Octagon Therapeutics, Inc. is a pharmaceutical company.
When was Octagon Therapeutics founded?
The earliest incorporation on record for Octagon Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences